Red blood cell alloimmunizations in beta-thalassemia patients in Casablanca/Morocco: Prevalence and risk factors.

[1]  S. Laradi,et al.  How to mitigate the risk of inducing transfusion-associated adverse reactions. , 2018, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

[2]  B. Ying,et al.  HLA‐DRB1*09:01 allele is associated with anti‐E immunization in a Chinese population , 2018, Transfusion.

[3]  M. Benajiba,et al.  Identification des allo-anticorps seuls et associés : bilan de trois années au centre régional de transfusion sanguine de Rabat/Maroc et difficultés de prise en charge transfusionnelle , 2017 .

[4]  Jérémie F. Cohen,et al.  Prevalence and risk factors for red blood cell alloimmunization in 175 children with sickle cell disease in a French university hospital reference centre , 2017, British journal of haematology.

[5]  A. Zidouh,et al.  [Identification of alloantibodies and their associations: Balance sheet of 3 years at the Regional Center of Blood Transfusion in Rabat/Morocco and difficult in transfusion management]. , 2017, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

[6]  M. Benajiba,et al.  Variants D partiels, D faibles et Del chez les donneurs de sang de phénotype RhD-négatif C/E + au Maroc , 2016 .

[7]  M. Benajiba,et al.  Polymorphisme des antigènes plaquettaires humains HPA chez les donneurs de sang au Maroc , 2016 .

[8]  O. Garraud.  Red blood cell antigen alloimmunization: Mysteries still unsolved , 2016, EBioMedicine.

[9]  R. Maitta,et al.  Alloimmunisation rates of sickle cell disease patients in the United States differ from those in other geographical regions , 2016, Transfusion medicine.

[10]  M. Cerino,et al.  Les thalassémies en 2016 , 2016 .

[11]  E. Payen,et al.  Current and future alternative therapies for beta-thalassemia major , 2016, Biomedical journal.

[12]  A. Winkler,et al.  Immunophenotypic parameters and RBC alloimmunization in children with sickle cell disease on chronic transfusion , 2015, American journal of hematology.

[13]  S. Datta,et al.  Frequency of Red Cell Alloimmunization and Autoimmunization in Thalassemia Patients: A Report from Eastern India , 2015, Advances in hematology.

[14]  Jamil M A S Obaid,et al.  Red blood cells alloimmunization and autoimmunization among transfusion-dependent beta-thalassemia patients in Alexandria province, Egypt. , 2015, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[15]  C. Westhoff,et al.  Changing practice: red blood cell typing by molecular methods for patients with sickle cell disease , 2015, Transfusion.

[16]  K. Eliaçık,et al.  Frequency of red cell allo- and autoimmunization in patients with transfusion-dependent beta thalassemia and affecting factors. , 2014, The Turkish journal of pediatrics.

[17]  L. Pierelli,et al.  Red blood cell alloimmunization in sickle cell disease and in thalassaemia: current status, future perspectives and potential role of molecular typing , 2014, Vox sanguinis.

[18]  E. Neufeld,et al.  Transfusion complications in thalassemia patients: a report from the Centers for Disease Control and Prevention (CME) , 2014, Transfusion.

[19]  A. Verma,et al.  Red Blood Cell Antibodies in Thalassemia Patients in Northern India: Risk Factors and Literature Review , 2014, Indian Journal of Hematology and Blood Transfusion.

[20]  S. Sheth,et al.  Regulatory B‐cell compartment in transfused alloimmunized and non‐alloimmunized patients with sickle cell disease , 2013, American journal of hematology.

[21]  C. Westhoff,et al.  High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors. , 2013, Blood.

[22]  I. Ben Amor,et al.  [Red blood cell immunization in haemoglobinopathie: about 84 cases]. , 2012, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

[23]  O. Garraud,et al.  Identification d’allo-anticorps et leurs associations : bilan d’une année à l’Établissement français du sang Auvergne-Loire , 2012 .

[24]  A. Thompson,et al.  Challenges of alloimmunization in patients with haemoglobinopathies , 2012, British journal of haematology.

[25]  E. Hod,et al.  Transfusion in the absence of inflammation induces antigen-specific tolerance to murine RBCs. , 2012, Blood.

[26]  Mohsen Saleh Elalfy,et al.  Red blood cell alloimmunization in transfusion‐dependent Egyptian patients with thalassemia in a limited donor exposure program , 2012, Transfusion.

[27]  I. Ben Amor,et al.  [Red blood cell immunization in haemoglobinopathie: about 84 cases]. , 2012, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

[28]  O. Garraud,et al.  [Identification of alloantibodies and their associations: balance sheet of a year at the Auvergne-Loire French Blood Establishment]. , 2012, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

[29]  C. Tournamille,et al.  Relevance of RH variants in transfusion of sickle cell patients. , 2011, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

[30]  M. Maghsudlu,et al.  Blood Transfusion and Alloimmunization in Patients with Thalassemia: Multicenter Study , 2011, Pediatric hematology and oncology.

[31]  E. Neufeld,et al.  Red cell alloimmunization in a diverse population of transfused patients with thalassaemia , 2011, British journal of haematology.

[32]  A. Raj,et al.  Antibody development in pediatric sickle cell patients undergoing erythrocytapheresis , 2010, Pediatric blood & cancer.

[33]  A. Brand,et al.  Red blood cell alloimmunization in sickle cell disease patients in Uganda , 2010, Transfusion.

[34]  S. Arruda,et al.  Alloimmunization and clinical profile of sickle cell disease patients from Salvador-Brazil. , 2010 .

[35]  I. Barjaktarevic,et al.  rs660 polymorphism in Ro52 (SSA1; TRIM21) is a marker for age-dependent tolerance induction and efficiency of alloimmunization in sickle cell disease. , 2009, Molecular immunology.

[36]  J. Vandenbroucke,et al.  Clinical predictors of alloimmunization after red blood cell transfusion , 2007, Transfusion.

[37]  M. Karimi,et al.  RBC alloimmunization in blood transfusion‐dependent β‐thalassemia patients in southern Iran , 2007, International journal of laboratory hematology.

[38]  F. Roudot-thoraval,et al.  Relative immunogenicity of Fya and K antigens in a Caucasian population, based on HLA class II restriction analysis , 2006, Transfusion.

[39]  A. Brand,et al.  Additional red blood cell alloantibodies after blood transfusions in a nonhematologic alloimmunized patient cohort: is it time to take precautionary measures? , 2006, Transfusion.

[40]  I. Chaudry,et al.  Splenectomy differentially influences immune responses in various tissue compartments of the body. , 2004, Cytokine.

[41]  F. A. Bhatti,et al.  Red cell immunization in beta thalassaemia major. , 2004, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP.

[42]  J. Semple.  Leucodepletion and immune response mechanisms , 2004, Vox sanguinis.

[43]  S. Al-Shemmari,et al.  RBC alloimmunization and autoimmunization among transfusion‐dependent Arab thalassemia patients , 2003, Transfusion.

[44]  F. Noizat-Pirenne.  Particularités immunohématologiques dans les populations africaines et antillaises. Implications transfusionnelles , 2003 .

[45]  B. Aygun,et al.  Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions , 2002, Transfusion.

[46]  E. Vichinsky,et al.  Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly asian descent. , 2000, Blood.

[47]  R. Ware,et al.  Erythrocyte autoantibodies in paediatric patients with sickle cell disease receiving transfusion therapy: frequency, characteristics and significance , 1999, British journal of haematology.

[48]  L. Rybicki,et al.  Multiple red cell transfusions and alloimmunization. Experience with 6996 antibodies detected in a total of 159,262 patients from 1985 to 1993. , 1995, Archives of pathology & laboratory medicine.

[49]  R. A. Johnson,et al.  Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. , 1990, The New England journal of medicine.

[50]  J. Peristeri,et al.  Red Cell Alloantibodies in Patients with Thalassemia , 1990, Vox sanguinis.

[51]  O. Castro,et al.  Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease. , 1990, Blood.

[52]  D. Dawson,et al.  Alloantibody responses in multiply transfused sickle cell patients. , 2008, Tissue antigens.

[53]  A. Karaklis,et al.  Alloimmunization to Red Cell Antigens in Thalassemia: Comparative Study of Usual versus Better‐Match Transfusion Programmes , 1987, Vox sanguinis.

[54]  G. Dunston,et al.  Association of HLA and autoantibody in transfused sickle cell disease patients , 1986, American journal of hematology.